Back    Zoom +    Zoom -
Sinopharm (01099.HK) Subsidiary Sinopharm Co (600511.SH) 1Q Net Profit RMB474M, Up 3.3%
Recommend
2
Positive
1
Negative
2
Sinopharm (01099.HK) announced that its subsidiary Sinopharm Co (600511.SH) released its first-quarter report. Revenue amounted to RMB13.555 billion, representing a YoY increase of 6.6%. Net profit attributable to shareholders reached RMB474 million, up 3.3%, with EPS at RMB0.6286. (de/d)



Related NewsSinopharm Group (01099.HK) Subsidiary Sinopharm Consistent (000028.SZ) 1Q Net Profit RMB287M, Down 12.4% YoY
This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.
Auto-translated by AI

AASTOCKS Financial News